FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed is application of dopamine agonist (for instance, amantadine, bromocriptine, cabergoline, quinagolide, lisuride, pergolide, ropinirole and pramipexole) for production of medication for treatment and prevention of endometriosis.
EFFECT: reduction of number of active endo-metrioid niduses, in treated niduses signs of atrophic or degenerative tissues were observed, ie reduction of number of endometrial glands under action of cabergoline.
14 cl, 6 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OR PREVENTION OF OVARY HYPERSTIMULATION SYNDROME (OHSS) WITH APPLICATION OF DOPHAMINE AGONIST | 2006 |
|
RU2416410C2 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2732251C1 |
| USE OF CABERGOLINE IN TREATING PATHOLOGICAL CONDITIONS CAUSED BY HIGH LEVELS OF THE VASCULAR ENDOTHELIAL GROWTH FACTOR | 2016 |
|
RU2698728C1 |
| N-ACETYL-L-CYSTEINE FOR TREATMENT OF ENDOMETRIOSIS | 2010 |
|
RU2549433C2 |
| METHOD OF TREATING ENDOMETRIOSIS IN EXPERIMENT IN RATS | 2023 |
|
RU2816983C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2018 |
|
RU2693050C1 |
| VETERINARY ANTI-PROLACTIN COMPOSITION FOR RUMINANTS | 2009 |
|
RU2528892C2 |
| METHOD FOR TREATMENT OF ENDOMETRIOSIS AND PREVENTION OF ITS RELAPSES | 2022 |
|
RU2787090C1 |
| METHOD OF ENDOMETRIOSIS TREATMENT BASED ON AN EXPERIMENTAL MODEL IN RATS | 2019 |
|
RU2711615C1 |
| METHOD OF TREATING EXTERNAL GENITAL ENDOMETRIOSIS | 2019 |
|
RU2727299C1 |
